C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Purchases Shares of 32,968 Henry Schein, Inc. (NASDAQ:HSIC)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 32,968 shares of the company’s stock, valued at approximately $2,281,000.

Other large investors have also made changes to their positions in the company. Sanctuary Advisors LLC bought a new stake in shares of Henry Schein during the second quarter valued at approximately $351,000. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after buying an additional 1,100 shares during the period. Bfsg LLC acquired a new position in shares of Henry Schein in the 3rd quarter valued at $205,000. Cardinal Capital Management lifted its holdings in shares of Henry Schein by 6.4% during the 3rd quarter. Cardinal Capital Management now owns 14,202 shares of the company’s stock worth $1,035,000 after acquiring an additional 857 shares during the period. Finally, Marathon Asset Management Ltd boosted its position in shares of Henry Schein by 3.2% during the 3rd quarter. Marathon Asset Management Ltd now owns 279,203 shares of the company’s stock valued at $20,354,000 after acquiring an additional 8,742 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 0.4 %

Shares of NASDAQ HSIC opened at $77.20 on Thursday. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The firm’s 50-day simple moving average is $73.85 and its 200 day simple moving average is $71.93. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.63 billion, a price-to-earnings ratio of 31.77, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on HSIC. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Jefferies Financial Group raised their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Thursday, January 30th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and a consensus price target of $80.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.